Literature DB >> 8902392

Recombinant Listeria monocytogenes cancer vaccines.

Y Paterson1, G Ikonomidis.   

Abstract

Listeria monocytogenes has recently been exploited as a vector for targeting antigens to the immune system. In the past year it has been shown to be particularly effective as a tumor antigen vector. Here we set its potency as a cancer vaccine in the context of the type of immunity induced by this facultative intracellular bacterium.

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8902392     DOI： 10.1016/s0952-7915(96)80083-5

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN： 0952-7915            Impact factor:   7.486


  15 in total

1.  Induction of human immunodeficiency virus (HIV)-specific CD8 T-cell responses by Listeria monocytogenes and a hyperattenuated Listeria strain engineered to express HIV antigens.

Authors:  R S Friedman; F R Frankel; Z Xu; J Lieberman
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

2.  In vitro properties of a Listeria monocytogenes bacteriophage-resistant mutant predict its efficacy as a live oral vaccine strain.

Authors:  Patricia A Spears; M Mitsu Suyemoto; Terri S Hamrick; Rebecca L Wolf; Edward A Havell; Paul E Orndorff
Journal:  Infect Immun       Date:  2011-09-19       Impact factor: 3.441

Review 3.  Listeriosis in human pregnancy: a systematic review.

Authors:  Ronald F Lamont; Jack Sobel; Shali Mazaki-Tovi; Juan Pedro Kusanovic; Edi Vaisbuch; Sun Kwon Kim; Niels Uldbjerg; Roberto Romero
Journal:  J Perinat Med       Date:  2011-04-25       Impact factor: 1.901

4.  Pathogenicity and immunogenicity of a vaccine strain of Listeria monocytogenes that relies on a suicide plasmid to supply an essential gene product.

Authors:  Xinyan Zhao; Zhongxia Li; Baiyan Gu; Fred R Frankel
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

5.  Conditional lethality yields a new vaccine strain of Listeria monocytogenes for the induction of cell-mediated immunity.

Authors:  Zhongxia Li; Xinyan Zhao; Darren E Higgins; Fred R Frankel
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

6.  A comparison of T cell memory against the same antigen induced by virus versus intracellular bacteria.

Authors:  A F Ochsenbein; U Karrer; P Klenerman; A Althage; A Ciurea; H Shen; J F Miller; J L Whitton; H Hengartner; R M Zinkernagel
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-03       Impact factor: 11.205

7.  Systemic immunity and mucosal immunity are induced against human immunodeficiency virus Gag protein in mice by a new hyperattenuated strain of Listeria monocytogenes.

Authors:  M V Rayevskaya; F R Frankel
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

8.  Listeria-based cancer vaccines that segregate immunogenicity from toxicity.

Authors:  Dirk G Brockstedt; Martin A Giedlin; Meredith L Leong; Keith S Bahjat; Yi Gao; William Luckett; Weiqun Liu; David N Cook; Daniel A Portnoy; Thomas W Dubensky
Journal:  Proc Natl Acad Sci U S A       Date:  2004-09-13       Impact factor: 11.205

9.  STING ligand c-di-GMP improves cancer vaccination against metastatic breast cancer.

Authors:  Dinesh Chandra; Wilber Quispe-Tintaya; Arthee Jahangir; Denise Asafu-Adjei; Ilyssa Ramos; Herman O Sintim; Jie Zhou; Yoshihiro Hayakawa; David K R Karaolis; Claudia Gravekamp
Journal:  Cancer Immunol Res       Date:  2014-06-09       Impact factor: 11.151

10.  High efficacy of a Listeria-based vaccine against metastatic breast cancer reveals a dual mode of action.

Authors:  Sun Hee Kim; Francisco Castro; Yvonne Paterson; Claudia Gravekamp
Journal:  Cancer Res       Date:  2009-07-07       Impact factor: 12.701
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.